BREO ELLIPTA (fluticasone furoate/vilanterol) Patient Assistance Program
Don’t let the high cost of brand specialty asthma/COPD inhalers disrupt your treatment. We help eligible patients access Breo Ellipta (fluticasone furoate/vilanterol) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Breo Ellipta (fluticasone furoate/vilanterol) is FDA-approved for the maintenance treatment of asthma in patients 5 years and older, and for the long-term, once-daily maintenance of airflow obstruction in COPD (chronic bronchitis and emphysema). It is a fixed-dose ICS/LABA combination delivered via the Ellipta inhaler.
- Without assistance, the average retail price runs approximately $400–$520 per Ellipta inhaler (30 doses, one month).
- Through AffordMyPrescriptions, qualifying patients can access Breo Ellipta for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no generic version of Breo Ellipta available in the U.S. as of 2026. Other ICS/LABA inhalers — including Advair Diskus (with generics) and Symbicort (with generics) — provide lower-cost alternatives.
What Is Breo Ellipta Prescription Assistance Program?
The Breo Ellipta Prescription Assistance Program is a manufacturer-sponsored initiative that provides Breo at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for asthma and COPD patients who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, prescriber coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your breathing, not paperwork.
Pharmacy Price Comparison
- Without assistance, Breo Ellipta costs roughly $400–$520 per inhaler. Generic ICS/LABA alternatives are typically much cheaper. A Patient Assistance Program is the meaningful path for brand pricing — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$500.00 | Save ~$430/inhaler |
| CVS Pharmacy | ~$520.00 | Save ~$450/inhaler |
| Walmart | ~$430.00 | Save ~$360/inhaler |
| Costco | ~$410.00 | Save ~$340/inhaler |
| Generic Advair (Wixela) | ~$110 | Already lower |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Breo Ellipta Prescription Program?
The Patient Assistance Program is free to apply for and provides Breo Ellipta at no medication cost if approved. But the process involves detailed applications, prescriber coordination, prior-authorization documentation, and ongoing renewal management. Our $69.95/month service covers full advocacy. Note: generic ICS/LABA inhalers (Wixela Inhub for Advair, Breyna for Symbicort) are widely available at significantly lower cost — we’ll guide you to the most cost-effective path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Breo Ellipta:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
- Still $400–$520 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Breo Ellipta assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Breo Ellipta Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Breo Ellipta:
Breo Ellipta (fluticasone furoate/vilanterol) is a once-daily, fixed-dose combination dry-powder inhaler used for the maintenance treatment of asthma (in patients 5 and older) and COPD. It combines an inhaled corticosteroid (fluticasone furoate) with a long-acting beta2-agonist (vilanterol) for both anti-inflammatory and bronchodilator effects.
How Breo Ellipta Works:
Breo Ellipta addresses the dual challenges of asthma and COPD by treating both airway inflammation and bronchoconstriction simultaneously. It combines fluticasone furoate, a corticosteroid that reduces inflammation over time, with vilanterol, a long-acting bronchodilator that relaxes airway muscles. This combination provides 24-hour symptom control with a single dose, offering a more convenient once-daily schedule than many traditional inhalers.
Form and use:
This medication is administered as one inhalation once daily via the Ellipta dry-powder inhaler. It is available in two strengths, though the higher 200/25 mcg dose is specifically for asthma and not for COPD. Each device contains 30 doses, and patients must rinse their mouth after use to prevent oral thrush. Breo is intended as a daily maintenance controller and must not be used as a rescue inhaler.
Generic availability:
As of 2026, there is no FDA-approved generic version of Breo Ellipta available in the United States. However, patients may consider other ICS/LABA combinations that do have lower-cost generic alternatives, such as Wixela Inhub or Breyna. Choosing an alternative depends on a prescriber’s evaluation of a patient’s inhaler technique, preferred dosing schedule, and overall clinical tolerability.
Warnings:
Breo Ellipta is not for acute symptom relief and carries warnings regarding pneumonia risk (especially in COPD) and localized infections like oral thrush. Important safety considerations include potential cardiovascular effects, such as palpitations or chest pain, and risks associated with LABA therapy. Patients should promptly report any worsening respiratory symptoms or heart-related issues to their healthcare provider.
FAQ (Frequently Asked Questions)
How Much Does Breo Ellipta Cost Without Insurance?
The average retail price runs approximately $400–$520 per Ellipta inhaler. Generic ICS/LABA alternatives (Wixela, Breyna) are widely available at significantly lower cost ($110+/inhaler). Through AffordMyPrescriptions, qualifying patients receive Breo at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Is Breo Different From Advair Or Symbicort?
Breo (fluticasone furoate/vilanterol) is dosed once daily. Advair (fluticasone propionate/salmeterol) and Symbicort (budesonide/formoterol) are dosed twice daily. Both Advair (as Wixela Inhub) and Symbicort (as Breyna) now have FDA-approved generics at significantly lower cost than Breo. Whether the once-daily convenience of Breo is worth the higher cost depends on your situation and adherence patterns.
Is This A Rescue Inhaler?
No. Breo Ellipta is a controller (maintenance) inhaler — taken once daily on a regular schedule. It is not for the acute treatment of asthma symptoms or COPD exacerbations. You should still have a separate short-acting rescue inhaler (typically albuterol) for sudden symptoms
Are There Cheaper Alternatives I Should Know About?
Yes. Generic ICS/LABA inhalers are widely available — Wixela Inhub (generic Advair, fluticasone propionate/salmeterol) and Breyna (generic Symbicort, budesonide/formoterol) typically run $110+ per inhaler. We mention this directly because for many patients, the generic ICS/LABA path is significantly cheaper than brand Breo.
How Do I Use The Ellipta Inhaler?
Open the cover until you hear a click. Breathe out fully (away from the inhaler). Place the mouthpiece in your mouth, close your lips around it, and inhale long and steadily. Hold your breath for 3–4 seconds. Close the cover. Rinse your mouth with water. The dose counter shows how many doses are left.
What If My Application Is Denied?
If your initial application is denied, we explore alternatives — switching to a generic ICS/LABA (Wixela Inhub, Breyna), the manufacturer’s copay savings program if you have commercial insurance, independent foundations such as the Asthma and Allergy Foundation of America, American Lung Association, COPD Foundation, PAN Foundation, or HealthWell Foundation, or asking your prescriber whether a different ICS/LABA combination would be appropriate. If we cannot find a path, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Breo Ellipta, our team may be able to help you access assistance programs — or guide you to a much cheaper generic ICS/LABA inhaler if it is the better fit. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.